Pfizer: The AI Hedge That Pays You To Stay Defensive

Pfizer remains an undervalued diversification play, underperforming the benchmark but increasing 2% since prior coverage. I view PFE as a defensive holding that pays investors to maintain a cautious stance in volatile markets. PFE offers an attractive opportunity to offset AI-related risks within a broader portfolio context. Despite recent underperformance, I maintain a bullish outlook on PFE for its strategic portfolio role and income potential.